GURUFOCUS.COM » STOCK LIST » USA » OTCPK » Virbac SA (OTCPK:VRBCF) » Definitions » Forward PE Ratio
Switch to:

Virbac (OTCPK:VRBCF) Forward PE Ratio

: 0.00 (As of Today)
View and export this data going back to . Start your Free Trial

Virbac's Forward PE Ratio for today is 0.00.

Virbac's PE Ratio without NRI for today is 20.71.

Virbac's PE Ratio for today is 20.71.

Virbac Forward PE Ratio Historical Data

The historical data trend for Virbac's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virbac Annual Data
Trend 2015-12 2016-04
Forward PE Ratio
30.40 0.02

Virbac Semi-Annual Data
2015-12 2016-03
Forward PE Ratio 30.40 0.02

Competitive Comparison

For the Drug Manufacturers - General subindustry, Virbac's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Virbac Forward PE Ratio Distribution

For the Drug Manufacturers industry and Healthcare sector, Virbac's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Virbac's Forward PE Ratio falls in comparison to its industry or sector. The grey bar indicates the Forward PE Ratio's extreme value range as defined by GuruFocus.

Virbac Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

Virbac  (OTCPK:VRBCF) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .

Virbac Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Virbac's Forward PE Ratio provided by Please click on the following links to see related term pages.

Virbac (OTCPK:VRBCF) Business Description

Virbac logo
Traded in Other Exchanges
2065m LID, 1 ere avenue, Carros, FRA, 06516
Virbac SA is a major drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by North America and Latin America. Most of the company's sales are generated from its Companion Animals segment, followed by its Food Producing Animals segment. Veterinarians remain Virbac's main client, yet the company's clients are particularly diverse throughout the world in terms of profession, size and expectations. Virbac's strategy focuses on dominating niche markets while either avoiding or remaining differentiated within the more competitive markets.

Virbac (OTCPK:VRBCF) Headlines

No Headlines